Background: Wide disparities in health status exist in the United States across race and
ethnicity, broadly driven by social determinants of health—most notably race and ethnic …

Sex differences in the anatomy and physiology of the respiratory system have been widely
reported. These intrinsic sex differences have also been shown to modulate the …

Pulmonary arterial hypertension (PAH) is a rare, complex, and deadly cardiopulmonary
disease. It is characterized by changes in endothelial cell function and smooth muscle cell …

Purpose Pulmonary hypertension (PH) is a heterogenous, often progressive disorder
leading to right heart failure and death. Previous analyses show stable PH mortality rates …

Background The epidemiology of pulmonary hypertension (PH) in patients with adult
congenital heart disease in Western countries is already known. We investigate clinical …

Rationale: There is a noticeable underrepresentation of minorities in clinical trials and
registries in pulmonary arterial hypertension (PAH). Prior studies evaluating the association …

Macitentan is an oral endothelin receptor antagonist for the management of pulmonary
arterial hypertension (PAH). The OPsumit® USers Registry (OPUS) and the OPsumit® …

Social determinants of health (SDoH) can impact the vulnerable pulmonary arterial
hypertension (PAH) population, especially during the COVID‐19 pandemic. Providers' …

Minoritized racial and ethnic groups suffer disproportionately from the incidence and
morbidity of pulmonary hypertension (PH), as well as its associated cardiovascular …

Conflict of interest statements: Dr RJ Bernardo serves on the medical advisory board for
Janssen Pharmaceuticals. Dr VA de Jesus Perez has no conflict of interest to declare …